Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD.
| Autor: | Fukushima, Yasushi, Nakatani, Yuji, Ide, Yumiko, Sekino, Hisakuni, Rose, Earl St, Siddiqui, Shahid, Maes, Andrea, Reisner, Colin |
|---|---|
| Zdroj: | International Journal of COPD; Apr2018, Vol. 13, p1187-1194, 8p, 2 Diagrams, 3 Charts |
| Databáze: | Complementary Index |
| Externí odkaz: |
|